Clinical Trial Update: Yttrium Y 90 Basiliximab and Combination Chemotherapy Before Stem Cell Transplant in Treating Patients With Mature T-cell Non-Hodgkin Lymphoma [Phase 1]

View source ↗

Summary

Phase 1 trial of Yttrium-90 labeled basiliximab with combination chemotherapy before stem cell transplant for mature T-cell and NK-cell non-Hodgkin lymphoma; st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous T-cell Lymphoma
• Mature T-cell Non-hodgkin Lymphoma
• Natural Killer Cell Non-hodgkin Lymphoma

Drugs mentioned

• Basiliximab (basiliximab)
• Yttrium-90 labeled basiliximab (yttrium-90-labeled basiliximab)

Snippet

Sponsor: City of Hope Medical Center | Conditions: Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma, Recurrent Mature T- and NK-Cell Non-Hodgkin Lymphoma | Phase 1 | Status: COMPLETED